**Core tip:** Metal hypersensitivity may be a cause of failure for total knee arthroplasty, although a clear correlation between metal sensitization and symptomatic knee after surgery has not been ascertained. Patients with a clear history of metal allergy, must be carefully examined through dermatological and laboratory testing before surgery. However, despite the increase in cutaneous and systemic hypersensitivity reactions to metals, which raise concern about joint arthroplasties, allergies against implant materials remain quite rare and an unexplored issue.

INTRODUCTION
============

Osteoarthritis is a degenerative disease affecting an important part of the population aged 65 or older, with a reported prevalence higher than 30% in the United States\[[@B1]\]. Its incidence increases with age and overweight status\[[@B2]\]. Its aetiology has not been completely clarified, but likely entails a multifactorial interplay of mechanical and biological causes. Various molecular mediators involved in the development of osteoarthritis have been identified\[[@B3]-[@B4]\], although their clinical relevance has yet to be demonstrated. Surgical therapy is required in cases of advanced osteoarthritis.

Total knee arthroplasty (TKA) is a common procedure performed in increasing numbers worldwide\[[@B5]\]. Despite its great success, up to 20% of patients still complain of unsatisfactory results\[[@B6]\]. Although several causes, such as infection or malalignment, have been shown to be most commonly responsible for dissatisfaction and poor outcomes, in the last decades another possible explanation has gained popularity: implant-related metal (or less frequently cement) hypersensitivity. In other words, an immunological reaction to the metallic portion of TKA components or to the bone cement\[[@B7],[@B8]\]. The hypothesis is supported by studies showing a higher prevalence of positive patch tests after TKA implantation\[[@B9]-[@B11]\]. However, even if local and systemic exposure to metals deriving from the implanted device can cause sensitization, the positivity of a metal test cannot be held as a proof of symptom causality\[[@B12]\]. As a matter of fact, it has also been shown that many patients who underwent TKA did not develop any complication after surgery, despite being sensitive to metal\[[@B13]\].

Looking at the epidemiologic data, 10% to 15% of the general population present dermatologic symptoms caused by metal hypersensitivity. Nickel is responsible in the majority of cases, while cobalt, chromium, beryllium and less frequently tantalum, titanium and vanadium are responsible for dermal symptomatology in a smaller number of cases\[[@B14]\]. However, taking into consideration patients undergoing TKA revision, it has been reported that less than 2% showed "metal related pathologies"\[[@B15]\]. Bone cement hypersensitivity is even more rare\[[@B16]\]. Therefore, it appears quite clear that the role of metal or cement allergies in TKA failures remains a controversial issue. The aim of the following paper is to provide an overview on diagnosis and management of metal hypersensitivity in patients who undergo a TKA in order clarify its real importance.

CAN PATIENTS WITH AN INCREASED RISK OF METAL HYPERSENSITIVITY BE RECOGNIZED BEFORE SURGERY?
===========================================================================================

Patient-reported allergies and history (family history, exposure, occupation, and self-reported allergies) are of utmost importance as a first diagnostic step. Although there are no guidelines, routine preoperative evaluation in patients reporting no history of adverse cutaneous reactions to metals or history of adverse events related to previous implant of metallic devices is not necessary and therefore not recommended. Moreover, use of conventional cobalt-chromium implants is also allowed without additional preoperative investigation, even in patients reporting only mild cutaneous reactions. An opposite consideration is that it is mandatory for patients reporting substantial cutaneous or systemic reactions to undergo patch testing before TKA\[[@B9],[@B17]\] (Figure [1](#F1){ref-type="fig"}).

![Preoperative diagnostic algorithm to select patients requiring hypersensitivity-friendly implants.](WJO-10-63-g001){#F1}

SYMPTOMS AND DIAGNOSIS
======================

After TKA implantation, clinical presentation of metal hypersensitivity is unspecific and symptoms are common to other complications. Metal hypersensitivity is a very rare condition and is usually a diagnosis of exclusion. The most common symptoms are joint effusion, swelling, stiffness, persistent pain at rest and decreased range of motion; less frequently, it is characterized by eczematous dermatitis, which can be local or generalized, extended to the neck, buttock and extremities\[[@B18]\]. Rarely, a general complication may occur, such as rhinitis, itching or asthma, hair loss and alopecia. The time range of first symptoms is variable, from 4 wk to 2 yr\[[@B19]\].

As a matter of fact, residual pain after TKA has many causes that need to be ruled out before a metal hypersensitivity is taken into consideration (Figure [2](#F2){ref-type="fig"}). An infection must be first ruled out by blood tests (erythrocyte sedimentation rate and C-reactive protein) and joint synovial fluid aspirations. Moreover, other common causes of pain, such as midflexion instability, component malalignment with patellar maltracking, crepitation and patellar clunk, can be ruled out by physical examination. Less common causes are early aseptic loosening and avascular necrosis of the patella\[[@B20]\]. Surely, a metal hypersensitivity should be suspected in patients with a clear self-reported history of metal reactions.

![Algorithm for diagnosis and treatment for metal hypersensitivity-related adverse reactions.](WJO-10-63-g002){#F2}

Radiographic images can show osteolytic lesions in the proximity of the femoral and tibial components, which formed as a result of the inflammatory response and can lead to aseptic loosening of the implant, loss of tibial posterior slope and setting of the tibial base plate into varus, as compared to the previous images taken after surgery\[[@B21]\]. The diagnostic algorithm is based on metal hypersensitivity aetiology. The immunological reactive mechanism to metallic components is still an unclear and debated issue. Metal hypersensitivity is generally a type IV allergic reaction, meaning that immune response acts through a delayed cell-mediated response, with activation of specific CD4+ T lymphocytes, macrophages, dendritic cells and other immune cells found within the synovial tissue. This response produces tissue inflammation and periprosthetic tissue damage, powered by the incretion of cytokines involved in the pro-inflammatory pathway, including interleukin (IL)-1, IL-12, IL-6, tumour necrosis factor and interferon-gamma. In particular, it must be highlighted that this mechanism of metal hypersensitivity is different from those that characterize lymphocyte-dominated non-septic vasculitis-associated lesions and pseudotumours that are reported as adverse local tissue reactions after metal-on-metal total hip arthtroplasty\[[@B18]\].

No generally accepted and reliable tests are available for the clinical diagnosis of metal hypersensitivity after TKA\[[@B22]\]. Patch test is the most frequent method used to diagnose contact allergy to metals and is, up to now, considered the gold standard. However, its validity faces a lot of controversy, and its sensitivity and specificity are 77% and 71%, respectively\[[@B18]\]. It is an *in vivo* test, widely available and easy to apply, so it can provide results within a few days. The hypothesis that cutaneous and systemic hypersensitivities are strictly related to the presence of metal after TKA is supported by a series of studies that found an important prevalence of positive patch tests after implantation of metallic TKA components. As already highlighted, the most common sensitizations to metal are with nickel, chromium and cobalt\[[@B19]\]. Patch test can be performed not only for metals but also for cement components, by using adhesive patches loaded with a known concentration of specific allergens compared with vaseline. However, patch tests also present some important limitations, namely skin reactions that are different compared with deep tissue layers and the joint environment, with the potential of an antigen-presenting mechanism being altered thereby. Patch tests also have different preparation and plots which can differ from subject to subject and tester to tester\[[@B23]\]. According to the published guidelines of the German Contact Allergy Group, patch testing should be exclusively regarded as a mean to "verify or exclude metal allergy in patients with a corresponding history"\[[@B24]\]. The American Contact Dermatitis Society has defined criteria for the diagnosis of post-implantation metal hypersensitivity contact dermatitis\[[@B25]\]. In particular, they proposed four major and six minor criteria, reported here in Table [1](#T1){ref-type="table"}.

###### 

Diagnostic criteria for post-implantation metal hypersensitivity\[[@B25]\]

  **Major criteria**
  ---------------------------------------------------------------------------------
  Eruption overlying the metal implant
  Positive patch test reaction to a metal used in the implant
  Complete recovery after removal of the offending implant
  Chronic dermatitis beginning weeks to months after metallic implantation
  **Minor criteria**
  Unexplained pain and/or failure of the offending implant
  Dermatitis reaction is resistant to therapy
  Morphology consistent with dermatitis (erythema, induration, papules, vesicles)
  Systemic allergic dermatitis reaction
  Histology consistent with allergic contact dermatitis
  Positive *in vitro* test to metals (*e.g*., lymphocytes transformation test)

Several laboratory assays have been proposed over the years. Lymphocyte transformation test is an *in vitro* test which analyses the proliferation of lymphocytes obtained by peripheral blood draw after contact with a metallic implant. It compares peripheral blood lymphocyte proliferation upon a 7 d incubation period, with and without the addition of metal antigen. Lymphocyte transformation test sensitivity is higher than patch testing, and provides quantifiable data and is very reproducible. Despite these positive aspects, this test is poorly available and there are a limited number of allergens that can be tested\[[@B19]\].

Even if many cytokines may be overexpressed in other conditions and diseases, enzyme-linked immunosorbent assay (commonly known as ELISA) testing can be used for measurement of cytokines released by stimulated cells.

Other *in vitro* tests are the Modified Lymphocyte Stimulation Test, the Lymphocyte Activation Test and the Leukocyte Migration Inhibition Test. The Modified Lymphocyte Stimulation Test has been described as a reliable test to diagnose systemic metal hypersensitivity, but it is currently impossible to use in large-scale settings because of its costs and limited availability\[[@B26]\]. The Lymphocyte Activation Test quantifies the expression of specific receptors (CD69) on circulating mononuclear cells after stimulation with metals. The Leukocyte Migration Inhibition Test measures the speed of migration of leukocytes after contact with sensitizing allergens. Another technique, even if not yet disseminated, is confocal microscopy, which can demonstrate intracellular abnormalities of the stimulated cells after contact with metals by 3D images obtained by computer tomography\[[@B23]\].

If the implant has to be removed, intra-operative biopsies and a consequential histopathological work-up can be used to confirm implant-related hypersensitivity. In those cases, periprosthetic membranes are characterized by a pronounced lymphocytes' infiltration\[[@B19]\]. At the histologic analysis of the synovial membrane, the characteristic pattern is granulation tissue and fibrosis, along with numerous giant cells and calcification. In support of the hypothesis that a chronic inflammatory response is the cause of synovitis, lymphocytic and plasma cell infiltrates in the surrounding synovial tissue have also been reported\[[@B18]\].

MANAGEMENT
==========

Management of patients with a suspicion of metal hypersensitivity is still not well defined. Once again, several authors have reported that patients with an ascertained diagnosis of metal allergy who underwent knee replacement with a metal-containing prosthetic device present no clinical evidence of metal hypersensitivity\[[@B27]\], and that no correlation between metal hypersensitivity and complications connected with the prosthesis could be found\[[@B28]\]. Therefore, although implant removal is surely a definitive solution, it must be considered very carefully, as a last option.

Good results have been reported after short-term therapy including topical steroids in the treatment of cutaneous dermatitis and non-steroidal anti-inflammatory drugs or physical therapy to manage pain caused by synovitis\[[@B29],[@B30]\]. By the end, if the symptoms do not resolve, one-stage revision surgery with a hypoallergenic implant should be considered. Resolution of symptoms after revision surgery is expected in 2-3 mo after surgery.

"HYPERSENSITIVITY-FRIENDLY" IMPLANTS
====================================

When a metal hypersensitivity has been diagnosed, surgeons need safe implants; many "hypersensitivity-friendly" knee arthroplasty components are currently available from various manufacturers. They can be divided in two categories: Coated implants and non-allergenic implants\[[@B23],[@B31]\].

Cobalt chrome (CoCr) implants coated with a hypersensitivity-friendly thin layer provide the advantage of retaining part of the superior tribological properties of CoCr; yet, the hypersensitivity-friendly layer, after scratching or wear can become damaged, exposing the underlying allergenic alloy\[[@B31]\]. Non-allergenic implants are made of non-CoCr alloys; while reducing the risk of exposure to allergenic metals, they usually show inferior physical properties compared to CoCr alloys\[[@B31]\]. They can be made of oxidized zirconium, pure titanium or ceramic femoral components associated with a tibial tray made of titanium or polyethylene\[[@B23]\].

The aim of the development of the Titanium Nitride (TiN) coating of knee implants was to improve their biocompatibility and mechanical properties\[[@B32]\]. TiN is applied as a 3--4 μm layer on CoCr implants\[[@B32]\]. In biomechanical studies, it has been shown to provide a 98% reduction of polyethylene wear\[[@B33]\]. Specifically, TiN showed a high resistance to adhesive wear and less adhesion to polyethylene; in addition, while CoCr catalyses polyethylene degradation, TiN is inert\[[@B34]\]. Sealing the CoCr surface, TiN reduces the cobalt and chromium ions release\[[@B32],[@B35]\], avoiding hypersensitivity reactions. Despite this theoretical advantage, in a clinical trial, no difference in metal sensitization and blood ion concentration has been found between coated and uncoated arthroplasties\[[@B26]\]. TiN-coated implants have shown good clinical and radiological results\[[@B36]\]. They were shown to have a 95.1% survival rate for any reason at 10 yr. When compared to a standard CoCr implant, they showed no difference in functional outcome, range of motion, revision rate and postoperative pain\[[@B37]\]. The titanium niobium nitride-coated implants showed similar results; comparison of the titanium niobium nitride implants with standard CrCo implants resulted in no statistical difference in clinical outcome scores, range of motion or radiographic evaluation at 1-yr follow-up\[[@B38]\].

Zirconium is a metal with physical properties resembling those of titanium. Its oxide, named zirconia, is a ceramic material. The coupled zirconium-oxidized zirconium has been used as a hybrid material to produce knee arthroplasty implants. It is composed of a core of solid metal, surrounded by a ceramic zirconium oxide (ZrOx) layer which cannot be considered as a coating but instead as the surface of the metal alloy\[[@B39]\]. This material couples the superficial wear characteristics of the ceramic zirconia and the strength of the internal metal. ZrOx causes less wear of the polyethylene than CoCr components and shows a better resistance to abrasion\[[@B40]\]. In an *in vitro* study, a reduction of 42% of polyethylene wear was demonstrated\[[@B41]\]. Containing no nickel, it is absolutely safe in metal-sensitive patients\[[@B37]\]. The ZrOx femoral component is usually coupled with a pure titanium tibial baseplate. A survival rate of 95%-98.7% has been reported at a 5-10 yr follow-up\[[@B42],[@B43]\]. No radiographic failures have been found in short-term\[[@B44]\] or long-term\[[@B43]\] follow up. In a clinical study comparing the results of ZrOx and CoCr arthroplasties implanted in patients undergoing simultaneous bilateral knee replacement, 44% of the patients perceived their knees as equivalent at a 5-yr follow-up\[[@B45]\].

Ceramic implants, being bioinert, represent a further choice for patients with metal hypersensitivity. These materials have a load to scratch that is 5 times greater than that of ZrOx and 10 times greater than CoCr, resulting in less wear of the surface and, consequently, less third-body wear of the polyethylene\[[@B46]\]. Among ceramics, zirconia is especially suitable for development of implants because of its tensile stress resistance and the possibility to shape it with a thickness similar to that of CoCr components\[[@B47]\]. Good clinical and radiographic results have been reported with these implants\[[@B47]-[@B49]\]; at 2-yr and 5-yr follow-up, neither clinical or radiological outcome nor revision rate difference between the CoCr and ceramic implants could be found\[[@B48],[@B49]\], and a survival rate of 97.4% at 10 yr and 94% at 15 yr has been reported\[[@B50],[@B51]\].

All-polyethylene tibial implants should provide the advantages of a thinner bone resection, thicker polyethylene implant and absence of locking mechanisms\[[@B52]\]. In a meta-analysis, no increased revision rates were found at 5 yr and 10 yr, when compared to metal-backed tibial components. No difference could be found for clinical and functional outcomes as well\[[@B53]\]. Should the patient be allergic to a substance contained in the cement, cementless implants are available. Advantages of cementless fixation are preservation of bone stock, provision of a biological fixation of the implant to the bone and avoidance of cement and its wear particles\[[@B54]\]. At 10 yr, a survival rate of 98.9% has been found\[[@B55]\]. In a recent meta-analysis, no difference could be found in terms of implant survivorship, clinical outcomes, radiological outcomes and complications between cemented and cementless implants\[[@B54]\].

CONCLUSIONS
===========

Metal hypersensitivity is a rare condition. Routine allergy testing or patch testing prior to TKA is not recommended, unless a clear history of local or systemic reactions has been reported. In cases of positive history and positive tests, a hypersensitivity-friendly implant should be considered. However, there is still a lack of evidence regarding correlation between metal hypersensitivity and implant-related complications. As a matter of fact, after TKA, one-stage revision surgery for metal or bone cement hypersensitivity should be considered only after ruling out most common causes of TKA failure and even after a short-term therapy aiming to solve cutaneous dermatitis and pain. In this paper, we report the up-to-date knowledge on metal hypersensitivity, suggesting how to make diagnosis of metal hypersensitivity, to treat the symptoms, and to avoid its presentation. Further studies are needed in order to reach a definitive conclusion on the role of metal ions in sensitization and development of implant-related metal hypersensitivity.
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